Valuation: UCB

Market Cap 40.34B 45.97B 37.92B 34.67B 64.79B 4,403B 65.27B 456B 177B 2,245B 173B 169B 7,278B P/E 2026 *
21.1x
P/E 2027 * 17.4x
Enterprise Value 40.65B 46.31B 38.21B 34.94B 65.28B 4,436B 65.77B 459B 178B 2,262B 174B 170B 7,334B EV / Sales 2026 *
4.68x
EV / Sales 2027 * 3.98x
Free-Float
61.59%
Yield 2026 *
0.69%
Yield 2027 * 0.71%
1 day-0.89%
1 week+2.67%
Current month-1.72%
1 month-4.56%
3 months-15.93%
6 months-14.88%
Current year-11.32%
1 week 207.6
Extreme 207.6
214.9
1 month 200.7
Extreme 200.7
226.2
Current year 200.7
Extreme 200.7
289.5
1 year 191.2
Extreme 191.2
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap. Importance
1/15/26 Exercice

Executive/Senior Manager

3,000 0.0015%
1/15/26 Exercice

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%+2.67%+3.52%+157.67% 46.58B
-0.26%+3.51%+41.19%-2.79% 80.27B
-0.25%+25.06%+606.13%+82.13% 72.88B
-0.12%+2.09%-10.95%-29.62% 61.51B
-1.80%-3.26%-13.41%+26.38% 47.39B
+0.96%+5.33%+63.33%-11.70% 33.3B
-1.80%-0.09%+47.43%+114.53% 25.73B
+0.29%+8.84%+9.19%+176.10% 22.88B
-1.92%0.00%+56.11%+100.00% 15.82B
-5.08%-3.79%+27.59%+140.96% 13.53B
Average -1.23%+5.43%+83.01%+75.37% 41.99B
Weighted average by Cap. -0.90%+7.09%+121.79%+53.85%

Financials

2026 *2027 *
Net sales 8.69B 9.91B 8.17B 7.47B 13.96B 949B 14.07B 98.17B 38.06B 484B 37.2B 36.39B 1,569B 9.68B 11.03B 9.1B 8.32B 15.54B 1,056B 15.66B 109B 42.36B 538B 41.4B 40.49B 1,746B
Net income 1.93B 2.2B 1.82B 1.66B 3.1B 211B 3.12B 21.81B 8.45B 107B 8.26B 8.08B 348B 2.32B 2.65B 2.19B 2B 3.73B 254B 3.76B 26.25B 10.18B 129B 9.95B 9.73B 419B
Net Debt 306M 348M 287M 263M 491M 33.34B 494M 3.45B 1.34B 17B 1.31B 1.28B 55.12B -1.81B -2.06B -1.7B -1.55B -2.9B -197B -2.92B -20.41B -7.91B -101B -7.73B -7.57B -326B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-09-23 €211.60 -0.89% 297,520
26-09-22 €213.50 +0.66% 227,356
26-09-21 €212.10 +1.92% 213,832
26-09-18 €208.10 -0.24% 554,518
26-09-17 €208.60 +1.21% 239,037
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
211.60EUR
Average target price
285.00EUR
Spread / Average Target
+34.69%

Quarterly revenue - Rate of surprise